QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 10 May 2006
doi: 10.1242/dev.02393

This Article Figures Only Full Text Full Text (PDF) Supplementary Material All Versions of this Article: dev.02393v1 133/12/2395    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Koide, T. Articles by Cho, K. W. Y. Search for Related Content PubMed PubMed Citation Articles by Koide, T. Articles by Cho, K. W. Y. Social Bookmarking                         What's this?

Negative regulation of Hedgehog signaling by the cholesterogenic enzyme 7-dehydrocholesterol reductase

Tetsuya Koide^*, Tadayoshi Hayata and Ken W. Y. Cho

Department of Developmental and Cell Biology, and Developmental Biology Center, University of California, Irvine, CA 92697-2300, USA.

Author for correspondence (e-mail: kwcho{at}uci.edu)

Accepted 4 April 2006

Cholesterol regulates Hedgehog (Hh) signaling during early vertebrate development. Smith-Lemli-Opitz syndrome (SLOS) is caused by defects in 7-dehydrocholesterol reductase (DHCR7), an enzyme catalyzing the final step of cholesterol biosynthesis. Many developmental malformations attributed to SLOS occur in tissues and organs where Hh signaling is required for development, but the precise role of DHCR7 deficiency in this disease remains murky. We report that DHCR7 and Sonic Hedgehog (Shh) are co-expressed during midline development in Xenopus embryos. DHCR7 has previously been implicated to function as a positive regulator of Hh signaling that acts to regulate the cholesterol adduction of Hh ligand or to affect Hh signaling in the responding cell. We present gain- and loss-of-function analyses suggesting that DHCR7 functions as a negative regulator of Hh signaling at the level or downstream of Smoothened (Smo) and affects intracellular Hh signaling. Our analysis also raises the possibility that the human condition SLOS is caused not only by disruption of the enzymatic role of DHCR7 as a reductase in cholesterol biosynthesis, but may also involve defects in DHCR7 resulting in derepression of Shh signaling.

Key words: Xenopus, Midline, Cholesterol, Floor plate, Smith-Lemli-Opitz syndrome (SLOS), Sonic hedgehog

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. S. Pappu, W. E. Connor, L. S. Merkens, J. M. Jordan, J. A. Penfield, D. R. Illingworth, and R. D. Steiner Increased nonsterol isoprenoids, dolichol and ubiquinone, in the Smith-Lemli-Opitz syndrome: effects of dietary cholesterol J. Lipid Res., December 1, 2006; 47(12): 2789 - 2798. [Abstract] [Full Text] [PDF]

				M. F. Bijlsma, M. P. Peppelenbosch, and C. A. Spek A dual role for 7-dehydrocholesterol reductase in regulating Hedgehog signalling? Development, October 15, 2006; 133(20): 3951 - 3951. [Full Text] [PDF]

				T. Koide, T. Hayata, and K. W. Y. Cho More challenges ahead of DHCR7's role in Hh signaling Development, October 15, 2006; 133(20): 3952 - 3953. [Full Text] [PDF]